Skip to main content

Emergency Medicine: Aspirin at Arrival for Acute Myocardial Infarction (AMI)

CBE ID
0092
1.4 Project
Cardiovascular
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Full Year 2016
Is Under Review
No
1.3 Measure Description

Percentage of patients, regardless of age, with an emergency department discharge diagnosis of acute myocardial infarction (AMI) who had documentation of receiving aspirin within 24 hours before emergency department arrival or during emergency department stay

    • 1.14 Numerator

      Patients who had documentation of receiving aspirin within 24 hours before emergency department arrival or during emergency department stay

    • 1.15 Denominator

      All patients, regardless of age, with an emergency department discharge diagnosis of AMI

    • Exclusions

      Documentation of medical reason(s) for patient not taking or receiving aspirin within 24 hours before emergency department arrival or during emergency department stay

      Documentation of patient reason(s) for not taking or receiving aspirin within 24 hours before emergency department arrival or during emergency department stay

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cardiovascular Project 2016-2017
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      Physician Consortium for Performance Improvement
      Steward Organization Email
      [email protected]
      Steward Organization Copyright

      Physician Performance Measures (Measures) and related data specifications, developed by the American Medical Association (AMA) in collaboration with the Physician Consortium for Performance Improvement (the Consortium) and the National Committee for Quality Assurance (NCQA) pursuant to government sponsorship under subcontract 6205-05-054 with Mathematica Policy Research, Inc. under contract 500-00-0033 with Centers for Medicare & Medicaid Services.
      These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.
      The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the Consortium) or NCQA. Neither the AMA, NCQA, Consortium nor its members shall be responsible for any use of the Measures.
      THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.
      © 2004-6 American Medical Association and National Committee for Quality Assurance. All Rights Reserved.
      Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, NCQA, the Consortium and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.